The Role of Interleukins in the Pathogenesis of Dermatological Immune-Mediated Diseases

Adv Ther. 2022 Oct;39(10):4474-4508. doi: 10.1007/s12325-022-02241-y. Epub 2022 Aug 23.

Abstract

Autoimmune inflammatory diseases are primarily characterized by deregulated expression of cytokines, which drive pathogenesis of these diseases. A number of approved and experimental therapies utilize monoclonal antibodies against cytokine proteins. Cytokines can be classified into different families including the interleukins, which are secreted and act on leukocytes, the tumor necrosis factor (TNF) family, as well as chemokine proteins. In this review article, we focus on the interleukin family of cytokines, of which 39 members have been identified to this date. We outline the role of each of these interleukins in the immune system, and various dermatological inflammatory diseases with a focused discussion on the pathogenesis of psoriasis and atopic dermatitis. In addition, we describe the roles of various interleukins in psychiatric, cardiovascular, and gastrointestinal comorbidities. Finally, we review clinical efficacy and safety data from emerging late-phase anti-interleukin therapies under development for psoriasis and atopic dermatitis. Collectively, additional fundamental and clinical research remains necessary to fully elucidate the roles of various interleukin proteins in the pathogenesis of inflammatory dermatologic diseases, and treatment outcomes in patients.

Keywords: Atopic dermatitis; Cytokine; Interleukin; Psoriasis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoimmune Diseases* / drug therapy
  • Cytokines
  • Dermatitis, Atopic* / drug therapy
  • Humans
  • Interleukins / therapeutic use
  • Psoriasis* / drug therapy
  • Tumor Necrosis Factor-alpha / therapeutic use

Substances

  • Cytokines
  • Interleukins
  • Tumor Necrosis Factor-alpha